Detecting mir-155-3p through a Molecular Beacon Bead-Based Assay

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Cancer Research

Background:

• Lung cancer (LC) is a leading cause of cancer-related mortality globally.
• MicroRNAs (miRNAs) show potential as biomarkers for disease detection and progression, including LC.
• Existing miRNA detection methods like PCR are often slow and costly.

Purpose of the Study:

• To develop and validate a rapid, sensitive, and cost-effective microfluidic assay for detecting miR-155-3p, a lung cancer biomarker.
• To utilize a molecular beacon (MB) bead-based assay integrated into a microfluidic device for enhanced miRNA detection.
• To assess the assay's performance in complex biological samples.

Main Methods:

• A microfluidic device was employed to immobilize molecular beacon (MB) probes for miRNA detection.
• The assay leverages fluorescence enhancement of MBs upon hybridization with the target miR-155-3p.
• Performance was evaluated using miR-155-3p in saline, A549 cell total RNA, and spiked peripheral blood mononuclear cells (PBMCs).

Main Results:

• The microfluidic MB assay successfully detected miR-155-3p with a limit of detection (LOD) of 42 nM in saline.
• Satisfactory recovery rates were achieved when testing the assay with A549 cell total RNA and spiked PBMCs.
• The assay demonstrated rapid and straightforward target detection capabilities.

Conclusions:

• The developed microfluidic molecular beacon assay provides a promising platform for sensitive and rapid detection of lung cancer-associated miRNAs.
• This approach offers a potential alternative to conventional, time-consuming miRNA quantification methods.
• Further validation in clinical samples could establish this assay for early lung cancer diagnosis.